Detalhe da pesquisa
1.
Tumor-derived interleukin-34 creates an immunosuppressive and chemoresistant tumor microenvironment by modulating myeloid-derived suppressor cells in triple-negative breast cancer.
Cancer Immunol Immunother
; 72(4): 851-864, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36104597
2.
Measurement of aerodynamic force and moment acting on a javelin using a magnetic suspension and balance system.
Sci Rep
; 13(1): 391, 2023 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36624172
3.
A mechanism of IL-34-induced resistance against cytotoxic anti-cancer therapies such as radiation by X-ray and chemotherapy by Oxaliplatin.
Oncoimmunology
; 12(1): 2238499, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37533702
4.
Interleukin-34 cancels anti-tumor immunity by PARP inhibitor.
J Gynecol Oncol
; 34(3): e25, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36603850
5.
Augmented interferon regulatory factor 7 axis in whole tumor cell vaccines prevents tumor recurrence by inducing interferon gamma-secreting B cells.
Oncoimmunology
; 12(1): 2213132, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37235066
6.
Erratum: Interleukin-34 Limits the Therapeutic Effects of Immune Checkpoint Blockade.
iScience
; 25(1): 103713, 2022 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35028541
7.
An optimized protocol for patient-derived xenograft in humanized mice to evaluate the role of IL-34 in immunotherapeutic resistance.
STAR Protoc
; 2(2): 100460, 2021 06 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33899027
8.
Interleukin-34 contributes to poor prognosis in triple-negative breast cancer.
Breast Cancer
; 27(6): 1198-1204, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32578004
9.
Bromodomain-containing protein 4 regulates interleukin-34 expression in mouse ovarian cancer cells.
Inflamm Regen
; 40: 25, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33072227
10.
Interleukin-34 Limits the Therapeutic Effects of Immune Checkpoint Blockade.
iScience
; 23(10): 101584, 2020 Oct 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33205010
11.
Prognostic value of IL-34 in colorectal cancer patients.
Immunol Med
; 42(4): 169-175, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31762401
12.
A role for IL-34 in osteolytic disease of multiple myeloma.
Blood Adv
; 3(4): 541-551, 2019 02 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-30782613
13.
Interleukin-34, a comprehensive review.
J Leukoc Biol
; 104(5): 931-951, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30066957
14.
Enhanced IL-34 expression in Nivolumab-resistant metastatic melanoma.
Inflamm Regen
; 38: 3, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29515691